UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:MYLK_NXPH1 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: MYLK_NXPH1 | KinaseFusionDB ID: KFG4027 | FusionGDB2.0 ID: KFG4027 | Hgene | Tgene | Gene symbol | MYLK | NXPH1 | Gene ID | 4638 | 30010 | |
Gene name | myosin light chain kinase | neurexophilin 1 | ||||||||||
Synonyms | AAT7|KRP|MLCK|MLCK1|MLCK108|MLCK210|MMIHS|MMIHS1|MSTP083|MYLK-L|MYLK1|smMLCK | NPH1|Nbla00697 | ||||||||||
Cytomap | 3q21.1 | 7p21.3 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | myosin light chain kinase, smooth musclekinase-related proteinmyosin, light polypeptide kinasesmooth muscle myosin light chain kinasetelokin | neurexophilin-1 | ||||||||||
Modification date | 20240403 | 20240305 | ||||||||||
UniProtAcc | Q86YV6 | P58417 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000346322, ENST00000354792, ENST00000359169, ENST00000360304, ENST00000360772, ENST00000475616, ENST00000418370, ENST00000510775, ENST00000578202, ENST00000583087, | ENST00000497400, ENST00000602349, ENST00000405863, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: MYLK [Title/Abstract] AND NXPH1 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MYLK(123367818)-NXPH1(8790638), # samples:3 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MYLK | GO:0030335 | positive regulation of cell migration | 19826488 |
Hgene | MYLK | GO:0051928 | positive regulation of calcium ion transport | 16284075 |
Hgene | MYLK | GO:0071476 | cellular hypotonic response | 11976941 |
Hgene | MYLK | GO:0090303 | positive regulation of wound healing | 15825080 |
Kinase Fusion gene breakpoints across MYLK (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across NXPH1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-BP-4781-01A | MYLK | chr3 | 123367818 | NXPH1 | chr7 | 8790638 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
ENST00000359169 | ENST00000405863 | MYLK | chr3 | 123367818 | NXPH1 | chr7 | 8790638 | 6653 | 1491 |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq >ENST00000359169_ENST00000405863_MYLK_chr3_123367818_NXPH1_chr7_8790638_length(amino acids)=1491 MAQLPQQTTEKTVTMGDVKLVASSHISKTSLSVDPSRVDSMPLTEAPAFILPPRNLCIKEGATAKFEGRVRGYPEPQVTWHRNGQPITSG GRFLLDCGIRGTFSLVIHAVHEEDRGKYTCEATNGSGARQVTVELTVEGSFAKQLGQPVVSKTLGDRFSAPAVETRPSIWGECPPKFATK LGRVVVKEGQMGRFSCKITGRPQPQVTWLKGNVPLQPSARVSVSEKNGMQVLEIHGVNQDDVGVYTCLVVNGSGKASMSAELSIQGLDSA NRSFVRETKATNSDVRKEVTNVISKESKLDSLEAAAKSKNCSSPQRGGSPPWAANSQPQPPRESKLESCKDSPRTAPQTPVLQKTSSSIT LQAARVQPEPRAPGLGVLSPSGEERKRPAPPRPATFPTRQPGLGSQDVVSKAANRRIPMEGQRDSAFPKFESKPQSQEVKENQTVKFRCE VSGIPKPEVAWFLEGTPVRRQEGSIEVYEDAGSHYLCLLKARTRDSGTYSCTASNAQGQLSCSWTLQVERLAVMEVAPSFSSVLKDCAVI EGQDFVLQCSVRGTPVPRITWLLNGQPIQYARSTCEAGVAELHIQDALPEDHGTYTCLAENALGQVSCSAWVTVHEKKSSRKSEYLLPVA PSKPTAPIFLQGLSDLKVMDGSQVTMTVQVSGNPPPEVIWLHNGNEIQESEDFHFEQRGTQHSLCIQEVFPEDTGTYTCEAWNSAGEVRT QAVLTVQEPHDGTQPWFISKPRSVTASLGQSVLISCAIAGDPFPTVHWLRDGKALCKDTGHFEVLQNEDVFTLVLKKVQPWHAGQYEILL KNRVGECSCQVSLMLQNSSARALPRGREPASCEDLCGGGVGADGGGSDRYGSLRPGWPARGQGWLEEEDGEDVRGVLKRRVETRQHTEEA IRQQEVEQLDFRDLLGKKVSTKTLSEDDLKEIPAEQMDFRANLQRQVKPKTVSEEERKVHSPQQVDFRSVLAKKGTSKTPVPEKVPPPKP ATPDFRSVLGGKKKLPAENGSSSAETLNAKAVESSKPLSNAQPSGPLKPVGNAKPAETLKPMGNAKPAETLKPMGNAKPDENLKSASKEE LKKDVKNDVNCKRGHAGTTDNEKRSESQGTAPAFKQKLQDVHVAEGKKLLLQCQVSSDPPATIIWTLNGKTLKTTKFIILSQEGSLCSVS IEKALPEDRGLYKCVAKNDAGQAECSCQVTVDDAPASENTKAPEMKSRRPKSSLPPVLGTESDATVKKKPAPKTPPKAAMPPQIIQFPED QKVRAGESVELFGKVTGTQPITCTWMKFRKQIQESEHMKVENSENGSKLTILAARQEHCGCYTLLVENKLGSRQAQVNLTVVDKPDPPAG TPCASDIRSSSLTLSWYGSSYDGGSAVQSYSIEIWDSANKTWKELATCRSTSFNVQDLLPDHEYKFRVRAINVYGTSEPSQESELTTVGE -------------------------------------------------------------- |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:123367818/chr7:8790638) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MYLK | NXPH1 |
FUNCTION: May be signaling molecules that resemble neuropeptides and that act by binding to alpha-neurexins and possibly other receptors. {ECO:0000305}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 1334_1426 | 14711 | 1915 | Domain | Note=Fibronectin type-III;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 1334_1426 | 14711 | 1864 | Domain | Note=Fibronectin type-III;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 1334_1426 | 14711 | 1915 | Domain | Note=Fibronectin type-III;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 1334_1426 | 14711 | 1864 | Domain | Note=Fibronectin type-III;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 33_122 | 14711 | 1915 | Domain | Note=Ig-like C2-type 1 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 33_122 | 14021 | 1846 | Domain | Note=Ig-like C2-type 1 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 33_122 | 14711 | 1864 | Domain | Note=Ig-like C2-type 1 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 33_122 | 14711 | 1915 | Domain | Note=Ig-like C2-type 1 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 33_122 | 14711 | 1864 | Domain | Note=Ig-like C2-type 1 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 161_249 | 14711 | 1915 | Domain | Note=Ig-like C2-type 2 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 161_249 | 14021 | 1846 | Domain | Note=Ig-like C2-type 2 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 161_249 | 14711 | 1864 | Domain | Note=Ig-like C2-type 2 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 161_249 | 14711 | 1915 | Domain | Note=Ig-like C2-type 2 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 161_249 | 14711 | 1864 | Domain | Note=Ig-like C2-type 2 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 414_503 | 14711 | 1915 | Domain | Note=Ig-like C2-type 3 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 414_503 | 14021 | 1846 | Domain | Note=Ig-like C2-type 3 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 414_503 | 14711 | 1864 | Domain | Note=Ig-like C2-type 3 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 414_503 | 14711 | 1915 | Domain | Note=Ig-like C2-type 3 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 414_503 | 14711 | 1864 | Domain | Note=Ig-like C2-type 3 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 514_599 | 14711 | 1915 | Domain | Note=Ig-like C2-type 4 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 514_599 | 14021 | 1846 | Domain | Note=Ig-like C2-type 4 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 514_599 | 14711 | 1864 | Domain | Note=Ig-like C2-type 4 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 514_599 | 14711 | 1915 | Domain | Note=Ig-like C2-type 4 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 514_599 | 14711 | 1864 | Domain | Note=Ig-like C2-type 4 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 620_711 | 14711 | 1915 | Domain | Note=Ig-like C2-type 5 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 620_711 | 14021 | 1846 | Domain | Note=Ig-like C2-type 5 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 620_711 | 14711 | 1864 | Domain | Note=Ig-like C2-type 5 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 620_711 | 14711 | 1915 | Domain | Note=Ig-like C2-type 5 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 620_711 | 14711 | 1864 | Domain | Note=Ig-like C2-type 5 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 721_821 | 14711 | 1915 | Domain | Note=Ig-like C2-type 6 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 721_821 | 14021 | 1846 | Domain | Note=Ig-like C2-type 6 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 721_821 | 14711 | 1864 | Domain | Note=Ig-like C2-type 6 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 721_821 | 14711 | 1915 | Domain | Note=Ig-like C2-type 6 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 721_821 | 14711 | 1864 | Domain | Note=Ig-like C2-type 6 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 1098_1186 | 14711 | 1915 | Domain | Note=Ig-like C2-type 7 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 1098_1186 | 14021 | 1846 | Domain | Note=Ig-like C2-type 7 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 1098_1186 | 14711 | 1864 | Domain | Note=Ig-like C2-type 7 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 1098_1186 | 14711 | 1915 | Domain | Note=Ig-like C2-type 7 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 1098_1186 | 14711 | 1864 | Domain | Note=Ig-like C2-type 7 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 23 | 31 | 1238_1326 | 14711 | 1915 | Domain | Note=Ig-like C2-type 8 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 25 | 33 | 1238_1326 | 14021 | 1846 | Domain | Note=Ig-like C2-type 8 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 33 | 1238_1326 | 14711 | 1864 | Domain | Note=Ig-like C2-type 8 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 26 | 34 | 1238_1326 | 14711 | 1915 | Domain | Note=Ig-like C2-type 8 |
Hgene | MYLK | 123367818 | NXPH1 | 8790638 | ENST00000359169 | 27 | 34 | 1238_1326 | 14711 | 1864 | Domain | Note=Ig-like C2-type 8 |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase Fusion Protein Structures |
CIF files of the predicted kinase fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Kinase Fusion protein CIF link (fusion AA seq ID in KinaseFusionDB) | Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | AA seq | Len(AA seq) |
PDB file >>>172_MYLK_NXPH1 | ENST00000359169 | ENST00000405863 | MYLK | chr3 | 123367818 | NXPH1 | chr7 | 8790638 | MAQLPQQTTEKTVTMGDVKLVASSHISKTSLSVDPSRVDSMPLTEAPAFILPPRNLCIKEGATAKFEGRVRGYPEPQVTWHRNGQPITSG GRFLLDCGIRGTFSLVIHAVHEEDRGKYTCEATNGSGARQVTVELTVEGSFAKQLGQPVVSKTLGDRFSAPAVETRPSIWGECPPKFATK LGRVVVKEGQMGRFSCKITGRPQPQVTWLKGNVPLQPSARVSVSEKNGMQVLEIHGVNQDDVGVYTCLVVNGSGKASMSAELSIQGLDSA NRSFVRETKATNSDVRKEVTNVISKESKLDSLEAAAKSKNCSSPQRGGSPPWAANSQPQPPRESKLESCKDSPRTAPQTPVLQKTSSSIT LQAARVQPEPRAPGLGVLSPSGEERKRPAPPRPATFPTRQPGLGSQDVVSKAANRRIPMEGQRDSAFPKFESKPQSQEVKENQTVKFRCE VSGIPKPEVAWFLEGTPVRRQEGSIEVYEDAGSHYLCLLKARTRDSGTYSCTASNAQGQLSCSWTLQVERLAVMEVAPSFSSVLKDCAVI EGQDFVLQCSVRGTPVPRITWLLNGQPIQYARSTCEAGVAELHIQDALPEDHGTYTCLAENALGQVSCSAWVTVHEKKSSRKSEYLLPVA PSKPTAPIFLQGLSDLKVMDGSQVTMTVQVSGNPPPEVIWLHNGNEIQESEDFHFEQRGTQHSLCIQEVFPEDTGTYTCEAWNSAGEVRT QAVLTVQEPHDGTQPWFISKPRSVTASLGQSVLISCAIAGDPFPTVHWLRDGKALCKDTGHFEVLQNEDVFTLVLKKVQPWHAGQYEILL KNRVGECSCQVSLMLQNSSARALPRGREPASCEDLCGGGVGADGGGSDRYGSLRPGWPARGQGWLEEEDGEDVRGVLKRRVETRQHTEEA IRQQEVEQLDFRDLLGKKVSTKTLSEDDLKEIPAEQMDFRANLQRQVKPKTVSEEERKVHSPQQVDFRSVLAKKGTSKTPVPEKVPPPKP ATPDFRSVLGGKKKLPAENGSSSAETLNAKAVESSKPLSNAQPSGPLKPVGNAKPAETLKPMGNAKPAETLKPMGNAKPDENLKSASKEE LKKDVKNDVNCKRGHAGTTDNEKRSESQGTAPAFKQKLQDVHVAEGKKLLLQCQVSSDPPATIIWTLNGKTLKTTKFIILSQEGSLCSVS IEKALPEDRGLYKCVAKNDAGQAECSCQVTVDDAPASENTKAPEMKSRRPKSSLPPVLGTESDATVKKKPAPKTPPKAAMPPQIIQFPED QKVRAGESVELFGKVTGTQPITCTWMKFRKQIQESEHMKVENSENGSKLTILAARQEHCGCYTLLVENKLGSRQAQVNLTVVDKPDPPAG TPCASDIRSSSLTLSWYGSSYDGGSAVQSYSIEIWDSANKTWKELATCRSTSFNVQDLLPDHEYKFRVRAINVYGTSEPSQESELTTVGE | 1491 |
3D view using mol* of 172_MYLK_NXPH1 | ||||||||||
PDB file >>>HKFP_251_MYLK_NXPH1 | ENST00000359169 | ENST00000405863 | MYLK | chr3 | 123367818 | NXPH1 | chr7 | 8790638 | MAQLPQQTTEKTVTMGDVKLVASSHISKTSLSVDPSRVDSMPLTEAPAFILPPRNLCIKEGATAKFEGRVRGYPEPQVTWHRNGQPITSG GRFLLDCGIRGTFSLVIHAVHEEDRGKYTCEATNGSGARQVTVELTVEGSFAKQLGQPVVSKTLGDRFSAPAVETRPSIWGECPPKFATK LGRVVVKEGQMGRFSCKITGRPQPQVTWLKGNVPLQPSARVSVSEKNGMQVLEIHGVNQDDVGVYTCLVVNGSGKASMSAELSIQGLDSA NRSFVRETKATNSDVRKEVTNVISKESKLDSLEAAAKSKNCSSPQRGGSPPWAANSQPQPPRESKLESCKDSPRTAPQTPVLQKTSSSIT LQAARVQPEPRAPGLGVLSPSGEERKRPAPPRPATFPTRQPGLGSQDVVSKAANRRIPMEGQRDSAFPKFESKPQSQEVKENQTVKFRCE VSGIPKPEVAWFLEGTPVRRQEGSIEVYEDAGSHYLCLLKARTRDSGTYSCTASNAQGQLSCSWTLQVERLAVMEVAPSFSSVLKDCAVI EGQDFVLQCSVRGTPVPRITWLLNGQPIQYARSTCEAGVAELHIQDALPEDHGTYTCLAENALGQVSCSAWVTVHEKKSSRKSEYLLPVA PSKPTAPIFLQGLSDLKVMDGSQVTMTVQVSGNPPPEVIWLHNGNEIQESEDFHFEQRGTQHSLCIQEVFPEDTGTYTCEAWNSAGEVRT QAVLTVQEPHDGTQPWFISKPRSVTASLGQSVLISCAIAGDPFPTVHWLRDGKALCKDTGHFEVLQNEDVFTLVLKKVQPWHAGQYEILL KNRVGECSCQVSLMLQNSSARALPRGREPASCEDLCGGGVGADGGGSDRYGSLRPGWPARGQGWLEEEDGEDVRGVLKRRVETRQHTEEA IRQQEVEQLDFRDLLGKKVSTKTLSEDDLKEIPAEQMDFRANLQRQVKPKTVSEEERKVHSPQQVDFRSVLAKKGTSKTPVPEKVPPPKP ATPDFRSVLGGKKKLPAENGSSSAETLNAKAVESSKPLSNAQPSGPLKPVGNAKPAETLKPMGNAKPAETLKPMGNAKPDENLKSASKEE LKKDVKNDVNCKRGHAGTTDNEKRSESQGTAPAFKQKLQDVHVAEGKKLLLQCQVSSDPPATIIWTLNGKTLKTTKFIILSQEGSLCSVS IEKALPEDRGLYKCVAKNDAGQAECSCQVTVDDAPASENTKAPEMKSRRPKSSLPPVLGTESDATVKKKPAPKTPPKAAMPPQIIQFPED QKVRAGESVELFGKVTGTQPITCTWMKFRKQIQESEHMKVENSENGSKLTILAARQEHCGCYTLLVENKLGSRQAQVNLTVVDKPDPPAG TPCASDIRSSSLTLSWYGSSYDGGSAVQSYSIEIWDSANKTWKELATCRSTSFNVQDLLPDHEYKFRVRAINVYGTSEPSQESELTTVGE | 1491_MYLK_NXPH1 |
Top |
Comparison of Fusion Protein Isoforms |
Superimpose the 3D Structures Among All Fusion Protein Isoforms * Download the pdb file and open it from the molstar online viewer. |
Comparison of the Secondary Structures of Fusion Protein Isoforms |
Top |
Comparison of Fusion Protein Sequences/Structures with Known Sequences/Structures from PDB |
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. * The blue color at the bottom marks the best active site residues. |
172_MYLK_NXPH1.png |
172_MYLK_NXPH1.png |
Top |
Potential Active Site Information |
The potential binding sites of these fusion proteins were identified using SiteMap, a module of the Schrodinger suite. |
Kinase Fusion AA seq ID in KinaseFusionDB | Site score | Size | Dscore | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
Top |
Ramachandran Plot of Kinase Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
172_MYLK_NXPH1_ramachandran.png |
Top |
Virtual Screening Results |
Distribution of the average docking score across all approved kinase inhibitors. Distribution of the number of occurrence across all approved kinase inhibitors. |
5'-kinase fusion protein case |
3'-kinase fusion protein case |
Top |
Drug information from DrugBank of the top 20 interacting small molecules. * The detailed information of individual kinase inhibitors are available in the download page. |
Fusion gene name info | Drug | Docking score | Glide g score | Glide energy |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Upadacitinib | -5.64225 | -5.64325 | -26.9665 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Pralsetinib | -5.32221 | -5.41371 | -50.7952 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Acalabrutinib | -5.322080000000001 | -5.336180000000001 | -39.6306 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Acalabrutinib | -5.322080000000001 | -5.336180000000001 | -39.6306 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Larotrectinib | -5.10669 | -5.10669 | -38.7028 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Abemaciclib | -4.95801 | -5.1601099999999995 | -35.3625 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Abemaciclib | -4.95801 | -5.1601099999999995 | -35.3625 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Abemaciclib | -4.95801 | -5.1601099999999995 | -35.3625 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Abemaciclib | -4.95801 | -5.1601099999999995 | -35.3625 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Larotrectinib | -4.906219999999999 | -4.906219999999999 | -40.3909 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Tofacitinib | -4.89417 | -4.90567 | -25.2723 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Tofacitinib | -4.89417 | -4.90567 | -25.2723 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Pralsetinib | -4.8535 | -4.945 | -48.8801 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Ponatinib | -4.7977099999999995 | -5.00431 | -46.49 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Ponatinib | -4.7977099999999995 | -5.00431 | -46.49 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Ponatinib | -4.7977099999999995 | -5.00431 | -46.49 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Asciminib | -4.7922199999999995 | -5.15532 | -34.3772 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Nilotinib | -4.73511 | -4.874709999999999 | -45.8303 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Nilotinib | -4.73511 | -4.874709999999999 | -45.8303 |
172_MYLK_NXPH1-DOCK_HTVS_1-001 | Abrocitinib | -4.69466 | -4.70576 | -36.2358 |
Top |
Kinase-Substrate Information of MYLK_NXPH1 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
MYLK | Q15746 | human | MYL2 | P10916 | S15 | KRAGGANsNVFsMFE | |
MYLK | Q15746 | human | MYL9 | P24844 | T19 | KKRPQRAtsNVFAMF | |
MYLK | Q15746 | human | MYL12B | O14950 | S20 | KRPQRAtsNVFAMFD | |
MYLK | Q15746 | human | MYL9 | P24844 | S20 | KRPQRAtsNVFAMFD | |
MYLK | Q15746 | human | MYL12B | O14950 | T19 | KKRPQRAtsNVFAMF |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
MYLK | ID | Description | 0.00e+00 |
MYLK | GO:0030239 | myofibril assembly | 1.24e-03 |
MYLK | GO:0055002 | striated muscle cell development | 1.24e-03 |
MYLK | GO:0010927 | cellular component assembly involved in morphogenesis | 2.55e-03 |
MYLK | GO:0006937 | regulation of muscle contraction | 3.36e-03 |
MYLK | GO:0055001 | muscle cell development | 3.36e-03 |
MYLK | GO:0031032 | actomyosin structure organization | 3.36e-03 |
MYLK | GO:0090257 | regulation of muscle system process | 4.06e-03 |
MYLK | GO:0051146 | striated muscle cell differentiation | 5.41e-03 |
MYLK | GO:0006936 | muscle contraction | 6.36e-03 |
MYLK | GO:0140694 | non-membrane-bounded organelle assembly | 7.40e-03 |
MYLK | GO:0042692 | muscle cell differentiation | 7.40e-03 |
MYLK | GO:0003012 | muscle system process | 7.89e-03 |
MYLK | GO:0055003 | cardiac myofibril assembly | 1.27e-02 |
MYLK | GO:0042693 | muscle cell fate commitment | 1.27e-02 |
MYLK | GO:0002026 | regulation of the force of heart contraction | 1.54e-02 |
MYLK | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.61e-02 |
MYLK | GO:0003229 | ventricular cardiac muscle tissue development | 3.01e-02 |
MYLK | GO:0055008 | cardiac muscle tissue morphogenesis | 3.01e-02 |
MYLK | GO:0003208 | cardiac ventricle morphogenesis | 3.13e-02 |
MYLK | GO:0070527 | platelet aggregation | 3.13e-02 |
MYLK | GO:0060415 | muscle tissue morphogenesis | 3.13e-02 |
MYLK | GO:0048644 | muscle organ morphogenesis | 3.26e-02 |
MYLK | GO:0055013 | cardiac muscle cell development | 3.31e-02 |
MYLK | GO:0055006 | cardiac cell development | 3.37e-02 |
MYLK | GO:0034109 | homotypic cell-cell adhesion | 3.37e-02 |
MYLK | GO:0006942 | regulation of striated muscle contraction | 3.37e-02 |
MYLK | GO:0001708 | cell fate specification | 3.61e-02 |
MYLK | GO:0003206 | cardiac chamber morphogenesis | 3.75e-02 |
MYLK | GO:0003231 | cardiac ventricle development | 3.75e-02 |
MYLK | GO:0055007 | cardiac muscle cell differentiation | 3.75e-02 |
MYLK | GO:0030168 | platelet activation | 3.75e-02 |
MYLK | GO:0060048 | cardiac muscle contraction | 3.75e-02 |
MYLK | GO:0008360 | regulation of cell shape | 3.75e-02 |
MYLK | GO:0035051 | cardiocyte differentiation | 4.24e-02 |
MYLK | GO:0003205 | cardiac chamber development | 4.24e-02 |
MYLK | GO:0006941 | striated muscle contraction | 4.50e-02 |
MYLK | GO:0030308 | negative regulation of cell growth | 4.50e-02 |
MYLK | GO:0008016 | regulation of heart contraction | 4.73e-02 |
MYLK | GO:0007596 | blood coagulation | 4.73e-02 |
MYLK | GO:0050817 | coagulation | 4.73e-02 |
MYLK | GO:0007599 | hemostasis | 4.73e-02 |
MYLK | GO:0060047 | heart contraction | 4.73e-02 |
MYLK | GO:0022604 | regulation of cell morphogenesis | 4.73e-02 |
MYLK | GO:0045926 | negative regulation of growth | 4.73e-02 |
MYLK | GO:0048738 | cardiac muscle tissue development | 4.73e-02 |
MYLK | GO:0003015 | heart process | 4.73e-02 |
MYLK | GO:1903522 | regulation of blood circulation | 4.73e-02 |
MYLK | GO:0003007 | heart morphogenesis | 4.73e-02 |
MYLK | GO:0014706 | striated muscle tissue development | 4.73e-02 |
Top |
Related Drugs to MYLK_NXPH1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning MYLK-NXPH1 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to MYLK_NXPH1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |